Keywords: Mylan, Teva, Provigil, Litigation, USA, Narcolepsy, Sleep apnea

Mylan settles Provigil litigation with Teva

Article | 10 June 2012

Print This

US generic major Mylan (Nasdaq: MYL) says that its subsidiary Mylan Pharmaceuticals has resolved all disputes with Teva Pharmaceuticals USA, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in